Pharmaceuticals: Europe Industry Guide is an essential resource for top-level data and analysis covering the Europe Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
* The European biotechnology market grew by 9.3% in 2007 to reach a value of $42,145 million.
* The European generics market generated total revenues of $32 billion in 2007, representing a compound annual growth rate (CAGR) of 13.6% for the period spanning 2003-2007.
* The European OTC pharmaceuticals market generated total revenues of $31.1 billion in 2008, representing a compound annual growth rate (CAGR) of 3.1% for the period spanning 2004-2008.
* The European pharmaceutical market generated total revenues of $177.6 billion in 2008, representing a compound annual growth rate (CAGR) of 4.4% for the period spanning 2004-2008.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
CHAPTER 1 BIOTECHNOLOGY IN EUROPE 9
1.1 Market Overview 9
1.2 Market Value 11
1.3 Market Segmentation I 12
1.4 Market Segmentation II 13
1.5 Five Forces Analysis 14
1.6 Market Forecasts 20
CHAPTER 2 GENERICS IN EUROPE 21
2.1 Market Overview 21
2.2 Market Value 23
2.3 Market Segmentation I 24
2.4 Market Segmentation II 25
2.5 Five Forces Analysis 26
2.6 Market Forecasts 33
CHAPTER 3 OTC PHARMACEUTICALS IN EUROPE 34
3.1 Market Overview 34
3.2 Market Value 36
3.3 Market Segmentation I 37
3.4 Market Segmentation II 38
3.5 Market Share 39
3.6 Five Forces Analysis 40
3.7 Distribution 47
3.8 Market Forecasts 48
CHAPTER 4 PHARMACEUTICALS IN EUROPE 49
4.1 Market Overview 49
4.2 Market Value 51
4.3 Market Segmentation I 52
4.4 Market Segmentation II 53
4.5 Market Share 54
4.6 Five Forces Analysis 55
4.7 Market Forecasts 63
CHAPTER 5 DEMOGRAPHICS 64
CHAPTER 6 APPENDIX 65
6.1 Data Research Methodology 65
LIST OF TABLES
Table 1: Europe Biotechnology Market Value: $ million, 2003-2007 11
Table 2: Europe Biotechnology Market Segmentation I: % Share, by Value, 2007 12
Table 3: Europe Biotechnology Market Segmentation II: % Share, by Value, 2007 13
Table 4: Europe Biotechnology Market Value Forecast: $ million, 2007-2012 20
Table 5: Europe Generics Market Value: $ billion, 2003-2007 23
Table 6: Europe Generics Market Segmentation I: % Share, by Value, 2007 24
Table 7: Europe Generics Market Segmentation II: % Share, by Value, 2007 25
Table 8: Europe Generics Market Value Forecast: $ billion, 2007-2012 33
Table 9: Europe OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 36
Table 10: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 37
Table 11: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 38
Table 12: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2007 39
Table 13: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 47
Table 14: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 48
Table 15: Europe Pharmaceuticals Market Value: $ million, 2003-2007 51
Table 16: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 52
Table 17: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 53
Table 18: Europe Pharmaceuticals Market Share: % Share, by Value, 2007 54
Table 19: Europe Pharmaceuticals Market Value Forecast: $ million, 2007-2012 63
Table 20: Europe Exchange Rate, 2003 64
LIST OF FIGURES
Figure 1: Europe Biotechnology Market Value: $ million, 2003-2007 11
Figure 2: Europe Biotechnology Market Segmentation I: % Share, by Value, 2007 12
Figure 3: Europe Biotechnology Market Segmentation II: % Share, by Value, 2007 13
Figure 4: Forces Driving Competition in the Biotechnology market in Europe, 2007 14
Figure 5: Drivers of Buyer Power in the Biotechnology market in Europe, 2007 15
Figure 6: Drivers of Supplier Power in the Biotechnology market in Europe, 2007 16
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology market in Europe, 2007 17
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology market in Europe, 2007 18
Figure 9: Drivers of Degree of Rivalry in the Biotechnology market in Europe, 2007 19
Figure 10: Europe Biotechnology Market Value Forecast: $ million, 2007-2012 20
Figure 11: Europe Generics Market Value: $ billion, 2003-2007 23
Figure 12: Europe Generics Market Segmentation I: % Share, by Value, 2007 24
Figure 13: Europe Generics Market Segmentation II: % Share, by Value, 2007 25
Figure 14: Forces Driving Competition in the Generics Market in Europe, 2007 26
Figure 15: Drivers of Buyer Power in the Generics Market in Europe, 2007 28
Figure 16: Drivers of Supplier Power in the Generics Market in Europe, 2007 29
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in Europe, 2007 30
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in Europe, 2007 31
Figure 19: Drivers of Degree of Rivalry in the Generics Market in Europe, 2007 32
Figure 20: Europe Generics Market Value Forecast: $ billion, 2007-2012 33
Figure 21: Europe OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 36
Figure 22: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 37
Figure 23: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 38
Figure 24: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2007 39
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in Europe 40
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Europe 41
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Europe 42
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Europe 43
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Europe 45
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Europe 46
Figure 31: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 47
Figure 32: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 48
Figure 33: Europe Pharmaceuticals Market Value: $ million, 2003-2007 51
Figure 34: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 52
Figure 35: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 53
Figure 36: Europe Pharmaceuticals Market Share: % Share, by Value, 2007 54
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in Europe, 2007 55
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in Europe, 2007 57
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in Europe, 2007 58
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Europe, 2007 60
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Europe, 2007 61
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Europe, 2007 62
Figure 43: Europe Pharmaceuticals Market Value Forecast: $ million, 2007-2012 63
Other selected research from the 'Europe' category:
eHealth Regulations in Europe: Understanding the Changing European Legislative Landscape
Pharmaceuticals: Europe Industry Guide
Other selected research from the 'Markets' category:
Partneringreview 2006 - Stage of development (volume 4)
Therapeutic Monoclonal Antibodies Report 2008-2023